TGTX icon

TG Therapeutics
TGTX

Overview Fund Activity

238 hedge funds and large institutions have $1.38B invested in TG Therapeutics in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 78 increasing their positions, 75 reducing their positions, and 35 closing their positions.

Holders
238
Holders Change
+5
Holders Change %
+2.15%
% of All Funds
3.45%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
44
Increased
78
Reduced
75
Closed
35
Calls
$55.2M
Puts
$38.6M
Net Calls
+$16.6M
Net Calls Change
-$5.06M

Top Buyers

1
SCM
1
Soleus Capital Management
Connecticut
$48.2M
2
SI
2
Sofinnova Investments
California
$30.2M
3
Bank of America
3
Bank of America
North Carolina
$33.5M
4
HRCM
4
Hood River Capital Management
Florida
$22.4M
5
Citadel Advisors
5
Citadel Advisors
Florida
$28.6M

Top Sellers

1
DGM
1
Darwin Global Management
Jersey
$0
2
PBA
2
Paradigm Biocapital Advisors
New York
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$17.8M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$16.5M
Name Market Value Shares Shares
Change 		Shares
Change %
CM
276
Caption Management
Oklahoma
– – – –
UOC
277
UBS O'Connor
Illinois
– – – –
8 9 10 11
12